Trial Profile

Phase III trial of Vonoprazan in Gastro-oesophageal (On-Demand) reflux

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 14 May 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vonoprazan (Primary)
Indications Gastro-oesophageal reflux; Heartburn
Focus Registrational; Therapeutic Use

Most Recent Events

09 May 2024 According to Phathom media release, company anticipates the initiation of this trial later this year.
07 Mar 2024 According to Phathom media release, this study is intended to support a future application for regulatory approval for novel dosing regimen of Vonoprazan.
06 Dec 2023 According to a Phathom Pharmaceuticals media release, the company is planning to initiate trial in 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com